¡¡
Pharma Koreana, Korea pharmaceutical news & reports, was established in 1991 and is now Korean leading pharmaceutical business newsletter. For the past years, Pharma Koreana has consistently provided senior executives in the pharmaceutical industry with the inside knowledge they need to compete and win! Readers are subscribers at the pinnacle of their careers as well as the rising stars of tomorrow. They turn to Pharma Koreana for its unique monthly package of Korean pharmaceutical news, analyses, commentaries and data. ¡¡
          
¡¡
There are 21 News items on Display.
Latest News¡¡

HighLight
1. Patent disputes between Pfizer and CJ

In 2011, CJ Cheiljedang filed a suit to nullify Pfizer¡¯s method-of-use patent for Viagra (sildenafil citrate) tab. for the treatment of erec ..
 

April 24th, 2012
2. Pharmaceutical wholesalers¡¯ profits rapidly decreased in 2011

Analysis of business performance of 106 pharmaceutical wholesalers showed that these wholesalers recorded a growth of 2 percent in sales, ..
 

April 24th, 2012
3. KOSPI-listed firms had an average R&D costs-to-sales ratio of 7.96% in 2011

Analysis of audit reports submitted by thirty two KOSPI-listed and eighteen KOSDAQ-listed pharmaceutical firms with the fiscal year ending i ..
 

April 17th, 2012
more ...
Business News
4. Active changes in pharmaceutical firms¡¯ positions in the market forecasted due to the changing environment of the pharmaceutical industry

According to a published report, the major pharmaceutical companies are drastically changing their strategies to cope with the changes broug ..
 

May 8th, 2012
5. Multinational pharmaceutical firms¡¯ average sales growth rate decreased over the two consecutive years

Analysis of business performance of twenty nine multinational pharmaceutical firms operating in Korea showed that these firms all together a ..
 

May 8th, 2012
6. Prices of top-selling OTC drugs raised

In April 2012, Ilyang Pharm raised the prices of its five OTC drugs such as Wonbi-D 100ml soln. (7.5 percent), Asthma-H 100ml syr. (14.3 per ..
 

May 8th, 2012
7. Hanmi acquires an exclusive license for a nasal spray version of diazepam for Korean and Chinese markets

Hanmi Pharm recently signed a license agreement with SK Biopharmaceuticals, a subsidiary firm of SK Group, to introduce a nasal spray vers ..
 

May 8th, 2012
8. Thirty one pharmaceutical firms showed a growth rate of more than 20% in the prescription drug market for out-patients in 1Q 2012

The growth rates of pharmaceutical firms, which achieved sales of more than \3.0 billion each in the prescription drug market for out-pati ..
 

May 8th, 2012
more ...
Policy and Regulatory
9. Licensing terms revised for Ildong¡¯s Flomox

Based on the results obtained from post-marketing surveillance (PMS) for Ildong Pharm¡¯s Flomox (cefcapene pivoxil hydrochloride) 75mg and 10 ..
 

May 8th, 2012
10. Patent-drug license linkage system enforced

To help the patent-drug license linkage system take root quickly, the Korean Intellectual Property Office (KIPO) plans to closely collabor ..
 

May 8th, 2012
more ...
Bio industry news
11. Ahngook expands and re-locates its bio/laboratory medicine R&D branch

In 2011, Ahngook Pharm established its bio/laboratory medicine R&D branch at Asan Medical Center¡¯s education and research building. Rece ..
 

May 8th, 2012
12. Functional 3-D scaffold for tissue engineering developed by Korean scientists

The Ministry of Education, Science and Technology (MEST) announced that a functional three-dimensional (3-D) scaffold for tissue engineeri ..
 

May 8th, 2012
13. Study results for Bukwang¡¯s novel antiviral agent against HBV reported

Bukwang Pharm recently reported the results of animal testing for FMCA phosphoramidate, a novel nucleoside-based drug candidate for the trea ..
 

May 2nd, 2012
more ...
R & D
14. Hanwha files its IND application for a new natural drug candidate for the treatment of diabetic endothelial dysfunction

Hanwha Pharm recently filed its Investigational New Drug (IND) application for YJP-14, a new natural drug candidate for the treatment of dia ..
 

May 2nd, 2012
15. Bukwang to develop a novel drug for the treatment of herpes zoster

Bukwang Pharm recently reported the results of animal testing for BHDU at the International Conference on Antiviral Research (ICAR) held in ..
 

May 2nd, 2012
16. KOSPI-listed firms had an average R&D costs-to-sales ratio of 7.96% in 2011

Analysis of audit reports submitted by thirty two KOSPI-listed and eighteen KOSDAQ-listed pharmaceutical firms with the fiscal year ending i ..
 

April 17th, 2012
more ...
Patent
17. Hanmi obtains a US patent for a novel targeted anticancer agent

Hanmi Holdings recently obtained a US patent entitled ¡®a novel amide derivative for inhibiting the growth of cancer cells¡¯. The patent relat ..
 

May 8th, 2012
18. Patent disputes between Pfizer and CJ

In 2011, CJ Cheiljedang filed a suit to nullify Pfizer¡¯s method-of-use patent for Viagra (sildenafil citrate) tab. for the treatment of erec ..
 

April 24th, 2012
19. Ildong obtains a patent for mass production of calcitriol

Ildong Pharm recently obtained a Korean patent entitled ¡®buffer composition for promoting the production of calcitriol or calcifediol and a ..
 

April 3rd, 2012
more ...
Company profile
20. Summary of Korea Pharmaceutical Manufacturer

Summary of Korea Pharmaceutical Manufacturer (Ildong Pharm & Handok Pharm) Please download the attached file.
 

April 2nd, 2012
21. Summary of Korea pharmaceutical manufacturers

Summary of Korea Pharmaceutical manufacturer (Sam Chun Dang Pharm)Please download the attached file.
 

March 2nd, 2012
more ...
¡¡
Pharma Koreana Ltd. 9F, KAMCO Yangjae Tower, 949-3, Dogok-dong Gangnam-gu, Seoul 135-270, Korea Tel:(82)2-554-9591 Fax:(82)2-563-8289 ¡¡ ¡¡

Email:Pkinfo@Pharmakoreana.com
Subscriptions:Pkinfo@Pharmakoreana.com
¡¡
¡¡